{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:58:51Z","timestamp":1792112331720,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1007\/s11883-003-0082-2","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T01:09:52Z","timestamp":1180055392000},"page":"114-117","source":"Crossref","is-referenced-by-count":19,"title":["Cyclooxygenase-2 inhibitors: Is there an association with coronary or renal events?"],"prefix":"10.1007","volume":"5","author":[{"given":"Richard J.","family":"Bing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"82_CR1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","volume":"231","author":"JR Vane","year":"1971","unstructured":"Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971, 231: 232\u2013235.","journal-title":"Nat New Biol"},{"key":"82_CR2","doi-asserted-by":"crossref","first-page":"33157","DOI":"10.1074\/jbc.271.52.33157","volume":"271","author":"WL Smith","year":"1996","unstructured":"Smith WL, Garavito RM, DeWitt DL: Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996, 271: 33157\u201333160.","journal-title":"J Biol Chem"},{"key":"82_CR3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","volume":"69","author":"WL Smith","year":"2000","unstructured":"Smith WL, DeWitt DL, Garavito RM: Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000, 69: 145\u2013182.","journal-title":"Annu Rev Biochem"},{"key":"82_CR4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0003-9861(92)90411-O","volume":"293","author":"SA Kraemer","year":"1992","unstructured":"Kraemer SA, Meade SA, DeWitt DL: Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start side and 5\u2032-flanking regulatory sequences. Arch Biochem Biophys 1992, 293: 391\u2013400.","journal-title":"Arch Biochem Biophys"},{"key":"82_CR5","doi-asserted-by":"crossref","first-page":"7991","DOI":"10.1016\/S0021-9258(18)42398-8","volume":"267","author":"DA Kujubu","year":"1992","unstructured":"Kujubu DA, Herschman HR: Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase\/cyclooxygenase gene. J Biol Chem 1992, 267: 7991\u20137994.","journal-title":"J Biol Chem"},{"key":"82_CR6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0008-6363(01)00250-4","volume":"51","author":"RJ Bing","year":"2001","unstructured":"Bing RJ: Myocardial ischemia and infarction: growth of ideas. Cardiovasc Res 2001, 51: 13\u201320.","journal-title":"Cardiovasc Res"},{"key":"82_CR7","first-page":"3385","volume":"7","author":"RJ Bing","year":"2001","unstructured":"Bing RJ, Miyataka M, Rich KA, et al.: Nitric oxide, prostanoids, cyclooxygenase and angiogenesis in colon and breast cancer. Clin Cancer Res 2001, 7: 3385\u20133392.","journal-title":"Clin Cancer Res"},{"key":"82_CR8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJM199209103271101","volume":"327","author":"MC Allison","year":"1992","unstructured":"Allison MC, Howatson AG, Torrance CJ, et al.: Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med 1992, 327: 749\u2013755.","journal-title":"N Engl J Med"},{"key":"82_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/PL00000770","volume":"58","author":"RJ Bing","year":"2001","unstructured":"Bing RJ: Some aspects of biochemistry of myocardial infarction. Cell Mol Life Sci 2001, 58: 1\u20135.","journal-title":"Cell Mol Life Sci"},{"key":"82_CR10","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1006\/bbrc.1994.2860","volume":"205","author":"R Dudek","year":"1994","unstructured":"Dudek R, Wildhirt S, Conforto A, et al.: Inducible nitric oxide synthase activity in myocardium after myocardial infarction in rabbit. Biochem Biophys Res Commun 1994, 205: 1671\u20131680.","journal-title":"Biochem Biophys Res Commun"},{"key":"82_CR11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/10623329509024667","volume":"3","author":"SM Wildhirt","year":"1995","unstructured":"Wildhirt SM, Dudek RR, Suzuki H, et al.: Expression of nitric oxide synthase isoforms after myocardial infarction in humans. Endothelium 1995, 3: 209\u2013224.","journal-title":"Endothelium"},{"key":"82_CR12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0024-3205(00)00678-0","volume":"67","author":"T Yamamoto","year":"2000","unstructured":"Yamamoto T, Kakar NR, Vina ER, et al.: The effect of aspirin and two nitric oxide donors on the infarcted heart in situ. Life Sci 2000, 67: 839\u2013846.","journal-title":"Life Sci"},{"key":"82_CR13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000056109","volume":"63","author":"T Yamamoto","year":"2001","unstructured":"Yamamoto T, Kakar NR, Vina ER, et al.: Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ. Pharmacology 2001, 63: 28\u201333.","journal-title":"Pharmacology"},{"key":"82_CR14","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jama.286.8.954","volume":"286","author":"D Mukherjee","year":"2001","unstructured":"Mukherjee D, Nissen SE, Topol EJ: Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001, 286: 954\u2013959.","journal-title":"JAMA"},{"key":"82_CR15","first-page":"2808","volume":"286","author":"M Fleming","year":"2001","unstructured":"Fleming M: Cardiovascular events and COX-2 inhibitors. JAMA 2001, 286: 2808.","journal-title":"JAMA"},{"key":"82_CR16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/01.CIR.101.4.430","volume":"101","author":"X Yang","year":"2000","unstructured":"Yang X, Ma N, Szabolcs MJ, et al.: Upregulation of COX-2 during cardiac allograft rejection. Circulation 2000, 101: 430\u2013438.","journal-title":"Circulation"},{"key":"82_CR17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0735-1097(01)01749-1","volume":"39","author":"RJ Bing","year":"2002","unstructured":"Bing RJ, Lomnicka M: Why do cyclo-oxygenase inhibitors cause cardiovascular events? J Am Coll Cardiol 2002, 39: 521\u2013522.","journal-title":"J Am Coll Cardiol"},{"key":"82_CR18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1126\/science.1068711","volume":"296","author":"Y Cheng","year":"2002","unstructured":"Cheng Y, Austin SC, Rocca B, et al.: Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 2002, 296: 539\u2013541.","journal-title":"Science"},{"key":"82_CR19","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/01.RES.27.5.765","volume":"27","author":"JC McGiff","year":"1970","unstructured":"McGiff JC, Crowshaw K, Terragno NA, et al.: Prostaglandin-like substances appearing in canine renal venous blood during renal ischemia. Circ Res 1970, 27: 765\u2013782.","journal-title":"Circ Res"},{"key":"82_CR20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0090-6980(73)90151-2","volume":"3","author":"MS Minkes","year":"1973","unstructured":"Minkes MS, Douglas JR Jr, Needleman P: Prostaglandin release by the isolated perfused rabbit heart. Prostaglandins 1973, 3: 439\u2013445.","journal-title":"Prostaglandins"},{"key":"82_CR21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.bi.55.070186.000441","volume":"55","author":"P Needleman","year":"1986","unstructured":"Needleman P, Turk J, Jakschik BA, et al.: Arachidonic acid metabolism. Annu Rev Biochem 1986, 55: 69\u2013102.","journal-title":"Annu Rev Biochem"},{"key":"82_CR22","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1172\/JCI117620","volume":"94","author":"RC Harris","year":"1994","unstructured":"Harris RC, McKanna JA, Akai Y, et al.: Cyclooxygenase-2 is associated with the macula densa of the rat kidney and increases with salt restriction. J Clin Invest 1994, 94: 2504\u20132510.","journal-title":"J Clin Invest"},{"key":"82_CR23","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1681\/ASN.V11122387","volume":"11","author":"RC Harris","year":"2000","unstructured":"Harris RC: Cyclooxygenase-2 in the kidney. J Am Soc Nephrol 2000, 11: 2387\u20132394.","journal-title":"J Am Soc Nephrol"},{"key":"82_CR24","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1161\/hy0302.105689","volume":"39","author":"M Miyataka","year":"2002","unstructured":"Miyataka M, Rich KA, Ingram M, et al.: Nitric oxide, anti-inflammatory drugs on renal prostaglandins and cyclooxygenase-2. Hypertension 2002, 39: 758\u2013789.","journal-title":"Hypertension"},{"key":"82_CR25","first-page":"F460","volume":"272","author":"M K\u00f6mhoff","year":"1997","unstructured":"K\u00f6mhoff M, Gr\u00f6ne HJ, Klein T, et al.: Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol 1997, 272: F460-F468.","journal-title":"Am J Physiol"},{"key":"82_CR26","doi-asserted-by":"crossref","first-page":"15280","DOI":"10.1073\/pnas.96.26.15280","volume":"96","author":"MZ Zhang","year":"1999","unstructured":"Zhang MZ, Harris RC, McKanna JA: Regulation of cyclooxygenase-2 (COX-2) in rat renal cortex by adrenal glucocorticoids and mineralocorticoids. Proc Natl Acad Sci U S A 1999, 96: 15280\u201315285.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"82_CR27","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1073\/pnas.091057698","volume":"98","author":"GM Rocha","year":"2001","unstructured":"Rocha GM, Michea LF, Peters EM, et al.: Direct toxicity of nonsteroidal antiinflammatory drugs for renal medullary cells. Proc Natl Acad Sci U S A 2001, 98: 5317\u20135322.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"82_CR28","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0272-6386(00)70266-6","volume":"35","author":"MA Perazella","year":"2000","unstructured":"Perazella MA, Eras J: Are selective COX-2 inhibitors nephrotoxic? Am J Kidney Dis 2000, 35: 937\u2013940.","journal-title":"Am J Kidney Dis"},{"key":"82_CR29","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.7326\/0003-4819-134-11-200106050-00018","volume":"134","author":"A Whelton","year":"2001","unstructured":"Whelton A: Cyclooxygenase-2 inhibition and renal function [letters]. Ann Intern Med 2001, 134: 1077\u20131078.","journal-title":"Ann Intern Med"},{"key":"82_CR30","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/S0002-9343(99)00113-8","volume":"106","author":"A Whelton","year":"1999","unstructured":"Whelton A: Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999, 106: 13S-24S.","journal-title":"Am J Med"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-003-0082-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-003-0082-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-003-0082-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T05:03:33Z","timestamp":1628917413000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-003-0082-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["82"],"URL":"https:\/\/doi.org\/10.1007\/s11883-003-0082-2","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}